Literature DB >> 749927

Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.

M E Pembrey, W G Wood, D J Weatherall, R P Perrine.   

Abstract

Fetal haemoglobin (HbF) levels have been measured in 137 normal (AA) subjects, 109 with the sickle-cell trait (AS) and 237 with sickle-cell anaemia (SS) from the oasis population of Eastern Saudi Arabia. In addition the proportion of F-cells has been estimated in 71 AA, 51 AS and 34 SS subjects. The mean HbF% (and the range of F-cells %) were: AA 0.77 (0.3--18), AS 1.38 (2.3--43) and SS 25.56 (33--98). The distribution of Hb F was always heterocellular. The influence of pregnancy accounts for most of the excess female subjects with sickle-cell trait showing raised Hb F and F-cells. Whilst the normal Arabs and those with sickle-cell trait did not differ from comparable groups of American blacks, both the % Hb F and % F-cells in Saudi Arabian patients with sickle-cell anaemia were much higher than in Blacks. The high Hb F levels in individuals with sickle-cell anaemia are not due to coexistent glucose-6-phosphate dehydrogenase deficiency or alpha-thalassaemia trait, and the Hb F level showed an inverse correlation with the degree of haemolysis. These findings indicate that the unusually elevated levels of Hb F are not due to an associated high frequency of a gene for hetero-cellular hereditary persistence of fetal haemoglobin in the oasis population, but rather from a genetically determined absolute increase in Hb F production related in some way to the SS genotype.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 749927     DOI: 10.1111/j.1365-2141.1978.tb05813.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  32 in total

Review 1.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

2.  Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.

Authors:  S M Jane; D L Gumucio; P A Ney; J M Cunningham; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 3.  Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.

Authors:  S Charache
Journal:  Experientia       Date:  1993-02-15

Review 4.  Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.

Authors:  Andrew Wilber; Arthur W Nienhuis; Derek A Persons
Journal:  Blood       Date:  2011-02-14       Impact factor: 22.113

5.  Heterogeneity of sickle cell anaemia in Arabs: review of cases with various amounts of fetal haemoglobin.

Authors:  K Kamel
Journal:  J Med Genet       Date:  1979-12       Impact factor: 6.318

6.  Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.

Authors:  C T Noguchi; G J Dover; G P Rodgers; G R Serjeant; S E Antonarakis; N P Anagnou; D R Higgs; D J Weatherall; A N Schechter
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

7.  Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.

Authors:  A M Omar; M A Mahran; M S Ghatge; N Chowdhury; F H A Bamane; M E El-Araby; O Abdulmalik; M K Safo
Journal:  Org Biomol Chem       Date:  2015-06-14       Impact factor: 3.876

8.  Regulation of fetal hemoglobin synthesis in sickle cell anemia.

Authors:  D G Nathan
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

Review 9.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

10.  Sickle cell disease in Saudi Arabs in early childhood.

Authors:  R P Perrine; P John; M Pembrey; S Perrine
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.